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Spectral studiesAbstract The chalcone of p-bromoacetophenone and p-chlorobenzaldehyde was prepared and
converted into aminopyrimidine by treating with guanidine nitrate. The aminopyrimidines so
obtained were converted into Schiff bases by treating with different substituted benzaldehydes.
The structures of synthesized compounds were confirmed by physical parameters and spectral stud-
ies such as UV, IR, and PMR. The synthesized Schiff bases were screened with different bacterial
species for the antibacterial activity by cup plate method and serial dilution technique. The confir-
mation of the biological activity of the final compounds was established by bioautography. The
mono and dihydroxy amino pyrimidines (I-g, I-j) of the novel series were found to be potential
against bacteria.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Antibacterial agents inhibit the growth and survival of microorganism
without any serious toxicity to the host. The life-threatening infectious
diseases caused by multidrug-resistant bacteria have been increased
day by day throughout the world. The spread of antibiotic resistance
has become a major problem for managing infectious diseases. But
for most of the antibacterial agents in clinical practice, resistance
was reported for at least one bacterial pathogen.However, because of the development of resistance by the organism
toward some bacteria-antibiotic combinations, their clinical utility was
severely declined from the market within a 5-year time span. The need
of antibiotics is closely tied to the rapidity and proliferation of resis-
tance developed by the organism and a number of other drugs used
for the same therapeutic indication. The recent flurry of research activ-
ity is to develop drugs for treating multidrug resistant (MDR) gram
positive bacteria, including MRSA (Methicillin resistant Staphylococ-
cus aureus), Pseudomonas aeruginosa, Stenotrophomonas maltophilia,
Acinetobacter spp., Enterococcus faecium, Enterobacteriaceae and
Mycobacterium tuberculosis.
There are always some unpredictable factors influencing the
antimicrobial drug discovery such as the appearance of new diseases,
or newly recognized association of established diseases with infectious
agents. Examples of previously unrecognized infectious diseases are
Legionnaire’s disease that was found to be associated with Legionella
pneumophila (Bush, 2004). Chalcones show various activities such asenyl)-2-
2 S. Prasad et al.anti-inflammatory, antibacterial and antifungal activities (Kalirajan
et al., 2009). Aminopyrimidines (2-,4-,5-,6-aminopyrimidines) were
reported for having various antibacterial (Rashinkar et al., 2009) anti-
fungal and antituberculosis (Patel et al., 2006) activities against differ-
ent microorganisms. Based on the above observations and in
continuation of our research on antimicrobial agents an attempt was
made here to synthesis the Schiff’s bases of amino pyrimidines
(Gulcan et al., 2012).
2. Materials and methods
All the chemicals used in this study were ordered and pur-
chased from sigma Aldrich chemicals. Melting point is carried
out in open capillary tube by using melting point apparatus
LAB INDIA MR-VIS Scientific. The purity of the compounds
was confirmed by TLC (pre-coated) SiO2 gel aluminum plates
(E MERK) using toluene: methanol: ethyl acetate (6:3:1) and
visualized by iodine chamber technique. IR spectra were
recorded on JASCO FT/IR-140 spectrophotometer. UV spec-
tra were recorded on JASCO V-530 UV/VIS spectrophotome-
ter. 1H NMR spectra were recorded on BRUKER ULTRA
SHIELDED NMR-300 MHZ.
2.1. Step 1: Synthesis of 3-(4-bromophenyl)-1-(4-chlorophenyl)
prop-2-en-1-one (I)
The compound (I) was synthesized by reported method
(Vogel’s text book 5th edition). A solution of 22 g of sodium
hydroxide in 200 ml of water and 100 ml of rectified spirit in
a 500 ml, bolt-head flask provided with a mechanical stirrer
was immersed in an ice bath (0.02 mole) of freshly distilled
p-bromoacetophenone. It was stirred and then 0.01 mole of
p-chlorobenzaldehyde was added. The temperature of the mix-
ture was maintained at 25 C and stirred vigorously until the
mixture was so thick that stirring was no longer effective. Then
the stirrer was removed and the reaction mixture was left in an
ice chest or refrigerator overnight. The product was filtered
with suction on a Buchner funnel, washed with cold water until
the washings are neutral to litmus and then again washed with
20 ml of ice-cold rectified spirit. The crude chalcone, after
dried in the air, was recrystallized from rectified spirit.
2.2. Step 2: Synthesis of 4-(4-bromophenyl)-6-(4-chlorophenyl)-
2-aminopyrimidine (I-1)
The compound (I-1) was synthesized by reported method
(Kumar et al., 2011). The chalcone (0.01 mole) was dissolved
in alcohol (25 ml) and guanidine nitrate (0.01 mole) was added
to it. Then a solution of potassium hydroxide (5 ml of 40%)
was added to the reaction mixture and refluxed for 10 h. The
reaction mixture was then cooled, poured into crushed ice
and product separated out was filtered, washed with water,
dried and recrystallized from alcohol.
2.3. Step 3: Synthesis of Schiff base (I-a–I-h)
The compounds (I-a–I-h) were synthesized by reported method
(Kadhim et al., 2014). A mixture of 4-(4-bromophenyl)-6-(4-c
hlorophenyl)-2-aminopyrimidine (0.01 mole) and substituted
benzaldehyde (0.01 mole) in ethanol (25 ml) with a few dropsPlease cite this article in press as: Prasad, S. et al., Synthesis, spectroscopic and antib
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for overnight until the precipitate is obtained. The solid sepa-
rated was filtered, dried and recrystallized from ethanol. The
purity of the product was established by single spot on the
TLC plate. The solvent system used was toluene: methanol:
ethyl acetate (6:3:1).
2.3.1. 3-(4-Bromophenyl)-1-(4-chlorophenyl) prop-2-en-1-one
(I)
Yield: 80%. M.p: 168.2 C. IR (mmax, cm1): 3419.17 (NAH),
1655.59 (AC‚O), 1602.56 (ArCAC), 1561.09 (NAO),
833.098 (CACl), 538.042 (CABr). 1H NMR: (DMSO-d6, d,
ppm): 8.192–8.289 (m, 8H, ArACH), 7.554 (d, 1H, a-H, Olefin
H), 7.755 (d, 1H, b-H, Olefin H). UV (kmax, DMSO): 320.
2.3.2. 4-(4-Bromophenyl)-6-(4-chlorophenyl) 2-
aminopyrimidine (I-1)
Yield: 70%. M.p: 177.7 C. IR (mmax, cm1): 3463.53 (NAH),
1639.2 (AC‚O), 1486.85 (ArCAC), 1579.41 (NAH),
804.171 (CACl) 492.723 (CABr). 1H NMR: (DMSO-d6, d,
ppm): 8.191–8.289 (m, 8H, ArACH), 7.755 (s, 1H,
Pyrimidine-H), 3.483 (s, 2H, ANH). UV (kmax, DMSO): 269.
2.3.3. [4-(4-Bromophenyl)-6-(4-chlorophenyl) pyrimidin-2-yl]-
1-(4-methoxyphenyl) methanimine (I-a)
Yield: 64%. M.p: 187.5 C. IR (mmax, cm1): 3464.49 (NAH),
1639.2 (AC‚O), 1594.84 (NAH), 1578.45 (ArCAC),
726.068 (CACl), 659.536 (CABr) 1H NMR: (DMSO-d6, d,
ppm): 8.192–8.289 (m, 12H, Ar CAH), 7.587 (s, H,
Pyrimidine-H) 9.855 (s, 1H, N‚CH) 3.603 (s, 3H, AOCH3).
UV (kmax, DMSO): 268.
2.3.4. [4-(4-Bromophenyll)-6-(4-chlorophenyl) pyrimidin-2-yl]-
1-(4-fluorophenyl) metanimine(I-b)
Yield: 60%. M.p: 183.8 C. IR (mmax, cm1): 3466.42 (NAH),
3306.36 (OAH), 3190.65 (CAH), 1640.16 (AC‚O), 1577.49
(ArCAC), 1456.96 (CAH), 1360.53 (ArCAN), 968.09
(OAH), 828.277 (CACl), 583.361 (CABr) 1H NMR:
(DMSO-d6, d, ppm): 7.321–8.289 (m, 12H, ArAH, s,1H,
HC‚C), 2.521 (s, 1H, HC‚N). UV (kmax, DMSO): 264.
2.3.5. [4-(4-Bromophenyl)-6-(4-chlorophenyl) pyrimidin-2-yl]-
1-(3,4-dimethoxyphenyl) methanimine (I-c)
Yield: 61%. M.p: 180.4 C. IR (mmax, cm1): 3466.42 (NAH),
2935.13 (CAH), 2719.14 (C‚O), 1680.66 (ArCAC), 1386.57
(ArCAN) 1134.9 (CAO), 808.028 (CACl), 583.361 (CABr).
1H NMR: (DMSO-d6, d, ppm): 7.588–8.288 (m, 11H, ArAH,
s, 1H, HC‚C), 2.522 (s, 1H, HC‚N), 3.394 (s, 3H, OCH3).
UV (kmax, DMSO): 258.
2.3.6. [4-(4-Bromophenyll)-6-(4-chlorophenyl) pyrimidin-2-yl]-
1-(3,4,5-trimethoxyphenyl)metanimine (I-d)
Yield: 55%. M.p: 176.6 C. IR (mmax, cm1): 3466.42 (NAH),
3306.36 (OAH), 3188.72 (CAH), 1640.16 (AC‚O), 1577.49
(ArCAC), 1457.92 (CAH) 1360.53 (ArCAN), 804 (CACl),
583.361 (CABr). 1H NMR: (DMSO-d6, d, ppm): 7.525–8.128
(m, 10H, ArAH, s, 1H, HC‚C), 2.514 (s, 1H, HC‚N),
3.376 (s, 3H, OCH3). UV (kmax, DMSO): 269.acterial studies of some schiﬀ bases of 4-(4-bromophenyl)-6- (4-chlorophenyl)-2-
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Synthesis, spectroscopic and antibacterial studies of some schiff bases 32.3.7. [4-(4-Bromophenyll)-6-(4-chlorophenyl) pyrimidin-2-yl]-
1-(3-nitrophenyl)metanimine (I-e)
Yield: 52%. M.p: 174.8 C. IR (mmax, cm1): 3467.38 (NAH),
1640.16 (AC‚O), 1578.45 (ArNAH), 1535.06 (ArCAC),Table 1 Zone of inhibition (mm) of antibacterial activity of
newly synthesized compounds.
Compound code Diameter of zone of inhibition (mm)
Gram positive
bacteria
Gram negative
bacteria
SA BS EC PA
I – – 15 mm 12 mm
I-1 17 mm 18 mm 18 mm 15 mm
I-a 15 mm 15 mm 17 mm 13 mm
I-b 13 mm 12 mm 15 mm 13 mm
I-c 15 mm 15 mm 12 mm 16 mm
I-d 11 mm 14 mm 12 mm –
I-e 14 mm 14 mm – 13 mm
I-f 14 mm 15 mm – 14 mm
I-g 16 mm 20 mm 18 mm 19 mm
I-h 11 mm 16 mm 18 mm 18 mm
I-i 14 mm 16 mm 18 mm 16 mm
I-j 19 mm 18 mm 18 mm 18 mm
I-k 14 mm 15 mm 18 mm 19 mm
I-L 15 mm 14 mm 16 mm 16 mm
Control – – – –
Ciprofloxacin 25 mm 26 mm 30 mm 26 mm
(–) Indicates no noticeable zone of inhibition.
SA = Staphylococcus aureus NCIM 2079, BS = Bacillus subtilis
NCIM 2063, EC = Escherichia coli NCIM 2911, PA = Pseu-
domonas aeruginosa NCIM 2036.
Table 2 Screening of minimal inhibitory concentration for sample
Minimal inhibitory concentration (lg/ml)
Compound codes Gram positive bacteria
SA BS
I 1000 1000
I-1 2000 2000
I-a 1000 2000
I-b 2000 2000
I-c 1000 2000
I-d 1000 1000
I-e 1000 1000
I-f 1000 1000
I-g 1000 1000
I-h 1000 1000
I-i 1000 1000
I-j 500 1000
I-k 1000 1000
I-L 500 1000
Dilutions for MIC
No of tubes for MIC 1 2 3 4
Concentration of drug (lg/ml) 4000 2000 1000 50
SA = Staphylococcus aureus NCIM 2079, BS = Bacillus subtilis NCI
aeruginosa NCIM 2036.
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(CABr). 1H NMR: (DMSO-d6, d, ppm): 7.586–8.286 (m,
12H, ArAH, s-1H, HC‚C) 2.517 (s, 1H, HC‚N). UV (kmax,
DMSO): 267.
2.3.8. [4-(4-Bromophenyll)-6-(4-chlorophenyl) pyrimidin-2-yl]-
1-(4-nitrophenyl)metanimine (I-f)
Yield: 50%. M.p: 178.6 C. IR (mmax, cm1): 3434.6 (NAH),
1487.81 (CAH), 1583.27 (ArCAC), 816.706 (CACl), 603.61
(CABr), 1675.84 (ArNAH), 1345.11 (ArCAN), 1267.97
(CAN). 1H NMR: (DMSO-d6, d, ppm): 7.586–8.283 (m,
12H, ArAH, s, 1H, HC‚C), 2.510–2.515 (s, 1H, HC‚N).
UV (kmax, DMSO): 266.
2.3.9. 4-[(E) {[4-(4-bromophenyl)-6-(4-chlorophenyl) pyrimidin-
2-yl]imino} methyl]phenol(I-g)
Yield: 62%. M.p: 194.6 C. IR (mmax, cm1): 3467.38 (NAH),
3308.29 (OAH) 1640.16 (C‚O), 1578.45 (ArNAH) 1535.06
(ArCAC), 1384.64 (ArCAN), 1376.53 (NAO), 805.135
(CACl), 585.29 (CABr). 1H NMR: (DMSO-d6, d, ppm):
7.295–8.288 (m, 12H, ArAH, s, 1H, HC‚C), 2.505–2.515 (s,
1H, HC‚N). UV (kmax, DMSO): 269.
2.3.10. [4-(4-Bromophenyll)-6-(4-chlorophenyl) pyrimidin-2-yl]-
1-(2-chlorophenyl)methanimine (I-h)
Yield: 60%. M.p: 191.8 C. IR (mmax, cm1): 3467.38 (NAH),
3307.32 (OAH), 3188.72 (CAH), 1640.16 (C‚O), 1577.49
(ArNAH), 1536.02 (ArCAC), 1486.85 (CAH) 1386.57
(ArCAN), 1360.53 (NAO) 968.09 (OAH), 804.171 (CACl),
584.325 (CABr). 1H NMR: (DMSO-d6, d, ppm): 7.586–8.284
(m, 12H, ArAH, s, 1H, HC‚C), 2.505–2.516 (s, 1H, HC‚N).
UV (kmax, DMSO): 266.with gram positive bacteria and gram negative bacteria.
Gram negative bacteria
ES PA
1000 2000
2000 2000
1000 1000
1000 2000
2000 2000
1000 1000
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500 1000
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500 500
5 6 7 8 9 10
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Table 3 Bio-autography of synthesized compounds with
Escherichia coli NCIM 2118.
Compound
code
Concentration
(lg/ml)
Rf
value
Zone of inhibition
(mm)
I 500 0.833 10
I-1 500 0.675 7
I-a 500 0.723 9
I-b 500 0.583 8
I-c 500 0.512 10
I-d 500 0.575 7
I-e 500 0.567 7
I-f 500 0.786 8
I-g 500 0.675 7
I-h 500 0.587 7
I-i 500 0.498 6
I-j 500 0.678 6
I-k 500 0.498 8
I-L 500 0.678 8
+ Br
O
CH 3
Cl
O
H
4-chlorobenzaldehyde
O
Cl Br
+
NH 2
NH
N
guanidine nitrate
N
N
Cl
Br
NH 2 +
O
H R
substituted
benzaldehyde
STEP 1
STEP 2
STEP 3
4-bromo acetophenone
chalcone
4-(4-bromophenyl)-6-(4-chlorophenyl)-
2-aminopyrimidine
CODE R1 R2 R3 R4
I-a H OCH3 H H
I-b H F H H
I-c H OCH3 OCH3 H
I-d OCH3 OCH3 OCH3 H 
I-e H H NO2 H
I-f H NO2 H H
Scheme
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pyrimidin-2-yl]limino}]-1-phenyl dimethyl amine (I-i)
Yield: 58%. M.p: 191.8 C. IR (mmax, cm1): 3465.46 (NAH),
1640.16 (C‚O), 1594.84 (ArNAH), 1536.02 (ArCAC),
1486.85 (CAH), 1383.68 (ArCAN), 1229.4 (CAN), 805.135
(CACl), 584.325 (CABr). 1H NMR: (DMSO-d6, d, ppm):
7.587–8.286 (m, 12H, ArAH, s, 1H, HC‚C), 2.500–2.511 (s,
1H, HC‚N). UV (kmax, DMSO): 270.
2.3.12. 4-[(E) {[4-(4-bromophenyl)-6-(4-chlorophenyl)
pyrimidin-2-yl]im no} methyl]benzene-1,3-diol (I-j)
Yield: 52%. M.p: 198.6 C. IR (mmax, cm1): 3466.42 (NAH),
3306.36 (OAH), 1640.16 (C‚O), 1592.91 (Ar NAH),
1536.99 (ArCAC), 1487.81 (CAH), 1388.5 (ArCAN),
1360.53 (NAO), 1228.43 (CAN), 969.055 (OAH), 848.525
(CACl), 550.577 (CABr). 1H NMR: (DMSO-d6, d, ppm):
7.586–8.283 (m, 11H, ArAH), 2.511–2.516 (s, 1H, HC‚N),
6.865 (s, 1H, OH). UV (kmax, DMSO): 264.O
Cl Br
H 2
HNO3
N             N
Cl Br
NH2
N
N
Cl
Br
N
R 1
R 2
R 3R 4
Schiff base
chalcone
4-(4-bromophenyl)-6-(4-chlorophenyl)-
2-aminopyrimidine
(I)
(I 1)-
CODE R1 R2 R3 R4
I-g H OH H H
I-h H H H Cl
I-i H CH3-N-CH3 H H 
I-j H OH H OH
I-k H H H H 
I-L H OH OCH3 H 
1
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Synthesis, spectroscopic and antibacterial studies of some schiff bases 52.3.13. [4-(4-Bromophenyl)-6-(4-chlorophenyl) pyrimidin-2-yl]-
1-phenylmethanimine(I-k)
Yield: 48%. M.p: 173.6 C. IR (mmax, cm1): 3467.38 (NAH),
1640.16 (C‚O), 1536.99 (Ar CAC), 804.171 (CACl), 584.325
(CABr), 1577.49 (ArNAH), 1385.6 (Ar CAN), 1228.43
(CAN), 3307.32 (OAH), 969.055 (OAH), 1487.81 (CAH),
1361.5 (NAO), 829.241 (‚CAH). 1H NMR: (DMSO-d6, d,
ppm): 7.587–8.286 (m, 13H, ArAH), 2.515–2.520 (s, 1H,
HC‚N). UV (kmax, DMSO): 265.
2.3.14. [4-(4-Bromophenyl)-6-(4-chlorophenyl) pyrimidin-2-yl]
imino}methyl]-2-methoxyphenol (I-L)
Yield: 51%. M.p: 174.6 C. IR (mmax, cm1): 3466.42 (NAH),
1639.2 (C‚O), 1536.99 (Ar CAC), 804.171 (CACl), 620.002
(CABr), 1579.41 (Ar NAH), 1385.6 (Ar CAN), 1227.47
(CAN), 1537.95 (CAC), 1486.85 (CAH), 1360.53 (NAO),
726.068 (CAH). 1H NMR: (DMSO-d6, d, ppm): 7.587–8.286
(m, 11H, ArAH), 2.502–2.514 (s, 1H, HC‚N), 6.862 (s, 1H,
OH), 3.366 (s, 3H, OCH3). UV (kmax, DMSO): 255.
3. Antibacterial activity
The newly synthesized compounds were screened for antibac-
terial activity. For antibacterial studies microorganisms such
as S. aureus NCIM 2079, Bacillus subtilis NCIM 2063, Escher-
ichia coli NCIM 2918, P. aeruginosa NCIM 2036 were used
(Table 1), and assayed by minimum inhibitory concentration
(MIC) by serial dilution technique. To determine MIC the
compounds were dissolved in dimethyl sulfoxide. Ciprofloxa-
cin was used as the standard and incubated for 24 h at 37 C
(Table 2).
4. Bio-autography
Bio-autography is carried out for all synthesized compounds.
This method is used quantitatively to determine low concentra-
tion of the synthesized compounds. The major concern for
quantization via bio-autography has been the evaluation of
the zone of the inhibition of the bio-autograph resulting from
the eluted TLC spot on precoated TLC plates by using toluene:
methanol:ethylacetate (6:3:1) (Table 3).
5. Results and discussion
The structures of all the synthesized compounds were deter-
mined on the basis of the FT/IR and 1H NMR data. The spec-
tral data of FT/IR and 1H NMR, confirm the structures of
newly synthesized compounds. The antibacterial activity of
the newly synthesized compounds (I-1, I-g, I-j) showed a good
activity against gram positive organisms (S. aureus, B. sub-
tilis), while other compounds show significant to moderate
activity. And the compounds (I-g, I-h, I-i, I-j, I-k) showedPlease cite this article in press as: Prasad, S. et al., Synthesis, spectroscopic and antib
aminopyrimidine. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.good activity against gram negative organisms (P. aeruginosa,
E. coli), other compounds show significant to moderate activ-
ity. All the synthesized compounds are subjected to Bioautog-
raphy. Compounds are elucidated on TLC plates with the
solvent system and kept for antimicrobial activity on the
media. All the compounds got clear zone of inhibition and
coincided with the Rf values of TLC, this confirms that all
the pure forms of the synthesized compounds only have the
antimicrobial activity (see Scheme 1).
6. Conclusion
Finally, the new aminopyrimidine Schiff bases derivatives were suc-
cessfully synthesized and evaluated for their antibacterial activity
and bioautography with significant results. The study states that the
synthesized compounds having potential antibacterial activity and
bioautography show the pure synthesized compounds only showing
the activity.
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